Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Furoscix® (furosemide) – Expanded indication
March 7, 2025 - scPharmaceuticals announced the FDA approval of Furoscix (furosemide), for the treatment of edema in adult patients with chronic heart failure or chronic kidney disease (CKD), including the nephrotic syndrome.
